According to our (Global Info Research) latest study, the global Plastic Biliary Stent market size was valued at US$ 56.16 million in 2025 and is forecast to a readjusted size of US$ 87.14 million by 2032 with a CAGR of 6.4% during review period.
Plastic Biliary Stent is the established market term for a sterile, single-use, radiopaque and non-self-expanding polymeric implant used to maintain biliary patency and provide temporary internal drainage. Also described as a plastic bile duct stent, biliary plastic stent or polymeric biliary stent, the product is placed mainly through endoscopic retrograde cholangiopancreatography, with selected systems supporting percutaneous-to-internal conversion. It is manufactured from polyethylene, polytetrafluoroethylene, polyurethane, ethylene-vinyl acetate or related medical-grade polymers and incorporates drainage side holes, radiopaque components and migration-control features such as flaps, bends or pigtail loops. The market covers stand-alone stents, stent-and-pusher sets, introducer systems and preloaded short-wire or long-wire delivery systems. Key specifications include French diameter, working length, geometry, polymer composition, guidewire compatibility and delivery configuration. Mainstream products concentrate at 7, 8.5 and 10 Fr, with common working lengths of 5–15 cm, while broader portfolios extend to approximately 11.5 Fr and 18 cm. The study focuses on straight-profile, pigtail and other specialty plastic biliary stents used for benign biliary strictures, temporary management of malignant obstruction, incomplete bile duct stone clearance, bile leakage, biliary fistula and related short- to medium-term drainage requirements.
Key Findings
In 2025, global Plastic Biliary Stent production reached approximately 483 K Units, with an average global market price of around US$ 113 per unit.
Mainstream plastic biliary stents cluster at 7, 8.5 and 10 Fr, with common working lengths of 5–15 cm
Straight-profile stents form the broadest unit segment, while pigtail and specialty designs address migration-sensitive anatomy
North America leads high-value demand, while Asia-Pacific contributes the strongest incremental unit growth
Market Trends
The product category is moving from basic polymer tubes toward procedure-optimized drainage systems. Development priorities include larger effective inner lumens, smoother internal surfaces, reduced sludge adhesion, stronger radiopacity, atraumatic tips and better control of migration without compromising removability. Boston Scientific’s Advanix platform emphasizes flow, pushability, repositionability and preloaded delivery, while Olympus uses a double-layer structure with a smoother inner surface to address patency and clogging concerns. These approaches illustrate competition shifting from polymer price toward total procedural efficiency and reliable short-term drainage. Short-wire compatibility, preloaded configurations and color-coded sizing reduce exchange steps and support standardized ERCP workflows. Demand is also becoming more application-specific: multi-stent protocols remain important for benign and post-transplant anastomotic strictures, pigtail designs are preferred where retention is critical, and readily removable plastic stents remain useful when diagnosis or treatment duration is uncertain. Plastic products will coexist with self-expanding metal stents rather than being fully replaced because they retain advantages in unit cost, removability, repeat placement and multi-duct drainage. Boston Scientific product portfolio Olympus double-layer stent
Market Dynamics
Drivers
Demand is supported by the continuing clinical burden of choledocholithiasis, benign postoperative and inflammatory strictures, pancreaticobiliary malignancies and complications following hepatobiliary surgery or liver transplantation. Expansion of therapeutic ERCP capacity increases the number of hospitals capable of placing and exchanging stents, while aging populations enlarge the patient pool requiring biliary decompression. Plastic stents generate recurring consumable demand because benign-stricture therapy may involve sequential dilation, multiple parallel stents and scheduled exchange. They are also required when complete stone extraction cannot be achieved during the initial ERCP, allowing temporary drainage before definitive treatment. Compared with permanent or longer-duration solutions, their removability supports staged treatment, uncertain pathology and bridge-to-surgery scenarios. Growth is additionally reinforced by broader availability of preloaded systems, compatible guidewires and standardized accessories, which improves procedural consistency and enables suppliers with integrated ERCP portfolios to bundle products, training and hospital support.
Restraints
Limited patency remains the main structural restraint. Bacterial biofilm, biliary sludge and side-hole blockage can lead to recurrent obstruction, cholangitis and unplanned replacement, while migration or difficult retrieval may create additional procedures. For longer-duration palliation of malignant obstruction, self-expanding metal stents can provide a larger lumen and longer patency, narrowing the role of conventional plastic products. Repeated ERCP also increases total treatment cost despite the lower unit price of the stent itself. Pricing pressure is pronounced in centralized procurement and hospital tenders: a 2025 Chinese hospital procurement notice budgeted an 8.5–10 Fr plastic biliary stent-and-guide system at RMB 892.04 per unit, illustrating the limited pricing headroom for standard configurations; the figure is a configuration-specific tender reference rather than a global average selling price. Reimbursement limitations, dependence on fluoroscopy and skilled endoscopists, and constrained ERCP access in lower-resource markets further restrict adoption. 2025 procurement notice.
Opportunities
The strongest opportunities lie in products that extend patency while preserving the cost and removability advantages of plastic. Low-friction inner layers, improved polymer formulations, anti-biofilm surfaces, optimized side-hole geometry and thin-wall construction could increase drainage performance without moving into metal-stent pricing. Preloaded and repositionable systems offer additional value by shortening procedure time and reducing accessory exchanges. Emerging Asian, Latin American and selected Middle Eastern markets provide incremental volume opportunities as ERCP training and tertiary-hospital infrastructure expand. Application-led growth can also arise from standardized multiple-plastic-stent protocols for benign strictures, transplant-related anastomotic disease, temporary drainage after difficult stone treatment and management of postoperative bile leaks. Specialized percutaneous-to-internal systems create a separate opportunity for interventional radiology departments and patients who cannot undergo conventional endoscopic placement. Manufacturers capable of pairing broad size matrices with local registration, physician education, reliable inventory and competitively priced delivery kits are best positioned to convert these opportunities into repeat sales.
Challenges
Manufacturers must balance lumen size, flexibility, pushability, kink resistance, radiopacity, migration control and atraumatic removal within a narrow polymer profile. Small variations in extrusion, side-hole cutting, flap formation or pigtail memory can materially affect placement and drainage performance, making manufacturing consistency critical. Regulatory requirements for biocompatibility, sterilization validation, shelf life, packaging integrity and post-market surveillance create meaningful barriers for smaller suppliers, particularly across the FDA, European MDR, NMPA and Japanese approval systems. Product differentiation is also difficult because established stent geometries are mature and clinicians often retain strong preferences for particular shapes, pushers and guidewire workflows. Price competition from regional manufacturers may compress margins before new materials or coatings achieve sufficient clinical evidence for premium positioning. At the same time, metal stents, endoscopic ultrasound-guided drainage and evolving stone-extraction technologies can reduce demand in selected indications. Suppliers therefore face the combined challenge of proving clinical value, maintaining a wide inventory of low-volume sizes and supporting geographically fragmented hospital procurement channels.
Industry Chain Analysis
The upstream chain comprises medical-grade polyethylene, PTFE, polyurethane and EVA polymers; radiopaque fillers or markers; colorants; guidewire-compatible tubing; stainless-steel or polymeric pusher components; and sterile barrier packaging. Midstream manufacturing involves precision extrusion, lumen control, thermal shaping, tapering, side-hole and flap formation, pigtail setting, radiopaque integration, assembly with pushers or introducers, cleanroom packaging and validated sterilization. Competitive value is created through consistent inner diameter, controlled stiffness, shape retention, visibility, drainage efficiency and compatibility with endoscopes and guidewires. Product owners may manufacture internally, use qualified OEM partners or combine proprietary delivery systems with outsourced polymer components. Downstream customers are hospitals, endoscopy centers, transplant and hepatobiliary units and, for selected products, interventional radiology departments. Sales occur through direct hospital accounts, group purchasing organizations, regional distributors and tender platforms. Because the stent itself uses relatively inexpensive polymer, a substantial share of value derives from design know-how, delivery-system integration, regulatory registration, quality assurance, inventory breadth, clinician training and dependable availability during urgent ERCP procedures.
Segment Insights
Straight Stent covers conventional straight, duodenal-bend, center-bend and Tannenbaum-style flapped products without curled retention ends; this category represents the broadest routine unit base because it supports multiple diameters, lengths and general drainage indications. Pigtail Stent includes single- and double-pigtail configurations and is differentiated by loop-based retention, making it relevant where migration prevention, stable cavity drainage or complex anatomy is important. Other comprises inside-stent designs, double-layer products, specialized preassembled geometries and percutaneous-to-internal conversion systems. Although smaller in volume, this category offers greater differentiation and potentially stronger pricing resilience.
Additional segmentation should be applied by material, diameter and delivery configuration. Material categories comprise polyethylene, PTFE, polyurethane, EVA and other polymer blends; diameter bands can be organized as up to 7 Fr, 8–8.5 Fr, 10 Fr, and above 10 Fr; delivery categories comprise stand-alone stents, stent-and-pusher sets and preloaded introducer systems. By application, benign biliary strictures and stone-related temporary drainage support recurring procedure volumes, malignant obstruction provides selective short-duration or bridge demand, and bile leak or biliary fistula represents a smaller but procedure-critical segment. This multidimensional structure is more decision-useful than classifying products solely by external shape.
Downstream Market Opportunities
Hospitals with therapeutic ERCP capability remain the primary end users, with tertiary referral centers contributing disproportionate demand for complex strictures, transplantation cases, hilar drainage and difficult stones. Community hospitals and ambulatory endoscopy centers offer opportunities for simplified preloaded products that reduce setup steps and training requirements. Benign stricture management is an attractive recurring-consumption application because treatment can require multiple simultaneous stents and scheduled exchanges. Stone-related drainage provides dependable procedural demand when infection, anatomy or stone size prevents immediate clearance, while postoperative bile leaks create time-sensitive requirements for readily available standard sizes. Interventional radiology represents a differentiated channel for plastic systems that convert external drainage to an internal stent. Suppliers can expand downstream penetration through procedure-specific kits, guidewire compatibility, consignment inventory, clinical education and digital inventory management rather than competing only on the price of an individual stent.
Regional Insights
North America remains the largest high-value regional market, supported by extensive therapeutic endoscopy infrastructure, established reimbursement pathways and strong adoption of integrated ERCP product platforms. Its competitive structure favors suppliers combining stents, guidewires, sphincterotomes, balloons and clinical support. Europe is another mature demand center, but procurement is more fragmented and MDR compliance increases registration and lifecycle-management costs, creating opportunities for established German and Belgian specialist manufacturers. Asia-Pacific provides the strongest incremental unit-growth potential. China combines expanding ERCP capacity, domestic manufacturing and tender-driven price competition; Japan maintains advanced clinical practice and demand for specialized inside, pigtail and multilayer designs; South Korea has strong therapeutic-endoscopy capability, while Southeast Asian demand depends more heavily on imported products and distributor networks. Latin America, the Middle East and Africa remain smaller but addressable markets, with growth concentrated in private hospitals and tertiary public centers. Across emerging regions, market access depends as much on training, registration and product availability as on nominal device price.
Competitive Landscape Analysis
Boston Scientific, Cook Medical and Olympus constitute the global core of the competitive landscape because they combine plastic stents with extensive ERCP instruments, delivery systems, physician relationships and multinational regulatory coverage. Boston Scientific differentiates through Advanix flow, repositionability and preloaded NaviFlex configurations; Cook Medical offers multiple established plastic-stent families and broad material, shape and delivery choices; Olympus competes through endoscopy-system integration and double-layer stent technology. Micro-Tech Endoscopy is a validated international challenger with plastic stents, introducers and short-wire-compatible sets cleared through the FDA’s 510(k) pathway. ENDO-FLEX, within the Medi-Globe Group, provides a wide PE/PTFE matrix covering straight, curved, angled and double-pigtail designs and should be consolidated with its group when evaluating competitive concentration. Hobbs Medical, optimed and G-Flex are credible specialist suppliers in the United States and Europe, while Japan Lifeline and Frankenman extend the verified regional manufacturer pool in Japan and China. Merit Medical Systems participates in a narrower interventional-radiology segment through its ReSolve ConvertX internalized plastic biliary stent and is not a direct like-for-like competitor across the full ERCP market. Competition centers on portfolio breadth, delivery reliability, polymer performance, regulatory access, hospital coverage and price rather than on a single proprietary stent mechanism.
Report Scope
This report is a detailed and comprehensive analysis for global Plastic Biliary Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plastic Biliary Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plastic Biliary Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plastic Biliary Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Plastic Biliary Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plastic Biliary Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plastic Biliary Stent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Cook Medical, Olympus Corporation, ENDO-FLEX GmbH, Micro-Tech Endoscopy, Merit Medical Systems, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Plastic Biliary Stent market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Straight Stent
Pigtail Stent
Other
Market segment by Polymer Material
Polyethylene
Polyurethane
Polytetrafluoroethylene
EVA Copolymer
Other
Market segment by Diameter
Diameter≤8Fr
Diameter 8-10Fr
Diameter>10Fr
Market segment by Application
Benign Biliary Strictures,Bbs
Malignant Biliary Obstruction
Bile Duct Stones
Gallbladder Leakage And Fistula
Other
Major players covered
Boston Scientific
Cook Medical
Olympus Corporation
ENDO-FLEX GmbH
Micro-Tech Endoscopy
Merit Medical Systems
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Plastic Biliary Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plastic Biliary Stent, with price, sales quantity, revenue, and global market share of Plastic Biliary Stent from 2021 to 2026.
Chapter 3, the Plastic Biliary Stent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plastic Biliary Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Plastic Biliary Stent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plastic Biliary Stent.
Chapter 14 and 15, to describe Plastic Biliary Stent sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Boston Scientific
Cook Medical
Olympus Corporation
ENDO-FLEX GmbH
Micro-Tech Endoscopy
Merit Medical Systems. Industry analysis & Market Report on Boston Scientific
Cook Medical
Olympus Corporation
ENDO-FLEX GmbH
Micro-Tech Endoscopy
Merit Medical Systems is a syndicated market report, published as Global Plastic Biliary Stent Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Boston Scientific
Cook Medical
Olympus Corporation
ENDO-FLEX GmbH
Micro-Tech Endoscopy
Merit Medical Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.